Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer
Open Access
- 21 April 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (9) , 4602
Abstract
Glioblastoma stem cells (GSCs) are cells with a self-renewal ability and capacity to initiate tumors upon serial transplantation that have been linked to tumor cell heterogeneity. Most standard treatments fail to completely eradicate GSCs, causing the recurrence of the disease. GSCs could represent one reason for the low efficacy of cancer therapy and for the short relapse time. Nonetheless, experimental data suggest that the presence of therapy-resistant GSCs could explain tumor recurrence. Therefore, to effectively target GSCs, a comprehensive understanding of their biology and the survival and developing mechanisms during treatment is mandatory. This review provides an overview of the molecular features, microenvironment, detection, and targeting strategies of GSCs, an essential information required for an efficient therapy. Despite the outstanding results in oncology, researchers are still developing novel strategies, of which one could be targeting the GSCs present in the hypoxic regions and invasive edge of the glioblastoma.Keywords
Funding Information
- Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (PN-II-ID-PCE-2011–3–1041)
This publication has 161 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesisEMBO Molecular Medicine, 2011
- Surgery for Glioblastoma Multiforme: Striking a BalanceWorld Neurosurgery, 2011
- NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53The EMBO Journal, 2010
- PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and GliomasCancer Cell, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Hypoxia inducible factors in cancer stem cellsBritish Journal of Cancer, 2010
- ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNSNeuropediatrics, 2008
- FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR statusJournal of Neuro-Oncology, 2007
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007